Brief: Innovative Pharmaceutical Biotech Sees Net Loss Of HK$550 Mln To HK$600 Mln For FY25
June 23 (Reuters) - Innovative Pharmaceutical Biotech Ltd 0399.HK: EXPECTED NET LOSS OF HK$550 MILLION TO HK$600 MILLION FOR FY2025 EXPECTED IMPAIRMENT LOSS OF HK$250 MILLION TO HK$350 MILLION ON INTANGIBLE ASSET Further company coverage: 0399.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU